Home » FDA Warning Asks Novartis for Global Manufacturing Assessment
FDA Warning Asks Novartis for Global Manufacturing Assessment
The FDA is asking Novartis for a comprehensive, global manufacturing assessment after it sharply scored the company for multiple repeated quality failures at plants operated by its Sandoz subsidiary.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May